OSYRIS

Comparison

NAD+ vs Epithalon — Different Clocks of Aging

A comparison of NAD+ and Epithalon as two different ways of framing longevity research: energy maintenance versus telomere maintenance.

7 min read Reviewed 2026-04-06
NAD plus versus Epithalon longevity comparison — OSYRIS Health

Two Clocks of Aging

NAD+ and Epithalon are often grouped under the same longevity banner, but they target different aging clocks. NAD+ is best understood through mitochondrial capacity, redox state, and NAD-dependent signaling. Epithalon is best understood through telomere and telomerase-related aging questions. One is about how well the cell functions. The other is about how long the cell can keep dividing cleanly.

Evidence and Translation

NAD+ benefits from a broader, more international evidence base. Epithalon is narrower and more concentrated in a specific lineage of telomere research. That does not make Epithalon unimportant. It makes the two compounds useful for different levels of confidence and different levels of specificity.

Why Researchers Still Consider the Combination

The combination rationale is straightforward: if one compound addresses mitochondrial decline and the other addresses telomere-linked decline, a multi-hallmark protocol may be more informative than a single-hallmark design. Whether that produces additive or synergistic results remains an open research question.

Featured Links

Questions

Common Questions

Which has the broader evidence base?

NAD+ has the broader evidence base overall.

Which is better for telomere research?

Epithalon is the clearer fit when the protocol is explicitly about telomere or telomerase-related questions.

Which is better for mitochondrial aging?

NAD+ is the clearer fit for mitochondrial, redox, and sirtuin-linked aging questions.

Can they be studied together?

Yes. They are rational partners in multi-hallmark aging protocols because they target different layers of the problem.

Is one more clinically validated than the other?

NAD+ is the more broadly discussed and cross-validated molecule in the literature.

Does OSYRIS present either as an anti-aging therapy?

No. Both are presented as research compounds for laboratory use only.